HB 534 KY

0likes☆Favorite🔕SubscribeShare

Became Law

Amend KRS 205.536 to prohibit the Department for Medicaid Services or a Medicaid managed care organization from requiring or using certain utilization reviews for prescription drugs that contain Naloxone; amend KRS 304.17A-611 to prohibit insurers from requiring or using certain utilization reviews for prescription drugs that contain Naloxone.

• R. Duvall Republican · primary

1. Feb 14, 2024 introduced in House · lower
2. Feb 14, 2024 to Committee on Committees (H) · lower
3. Feb 23, 2024 to Health Services (H) · lower
4. Feb 29, 2024 reported favorably, 1st reading, to Calendar with Committee Substitute (1) · lower
5. Mar 1, 2024 2nd reading, to Rules · lower
6. Mar 5, 2024 posted for passage in the Regular Orders of the Day for Wednesday, March 06, 2024 · lower
7. Mar 6, 2024 3rd reading, passed 94-0 with Committee Substitute (1) · lower
8. Mar 7, 2024 received in Senate · upper
9. Mar 7, 2024 to Committee on Committees (S) · upper
10. Mar 13, 2024 to Banking & Insurance (S) · upper
11. Mar 21, 2024 reported favorably, 1st reading, to Consent Calendar · lower
12. Mar 22, 2024 2nd reading, to Rules as a consent bill · lower
13. Mar 25, 2024 posted for passage in the Consent Orders of the Day for Tuesday, March 26, 2024 · lower
14. Mar 26, 2024 passed over and retained in the Consent Orders of the Day · lower
15. Mar 27, 2024 passed over and retained in the Consent Orders of the Day · lower
16. Mar 28, 2024 3rd reading, passed 37-1 · lower
17. Mar 28, 2024 received in House · lower
18. Mar 28, 2024 enrolled, signed by Speaker of the House · lower
19. Mar 28, 2024 enrolled, signed by President of the Senate · upper
20. Mar 28, 2024 delivered to Governor · lower
21. Apr 9, 2024 signed by Governor (Acts Ch. 155) · lower

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

• Acts Chapter 155 · PDF
• Current/Final · PDF
• Introduced · PDF